Abstract
Introduction: Autoimmune polyglandular syndrome type 2 (APS-II) is a rare disorder characterized by the coexistence of primary adrenal insufficiency with autoimmune thyroid disease and/or type 1 diabetes mellitus. It may also be associated with other endocrine and non-endocrine autoimmune conditions.
Objective: To report a clinical case of autoimmune polyglandular syndrome type 2 and highlight the importance of its timely recognition in clinical practice.
Case presentation: A 33-year-old woman with a history of autoimmune hypothyroidism and vitiligo presented with constitutional symptoms and cutaneous manifestations. Evaluation revealed adrenal crisis, hypergonadotropic hypogonadism, the presence of positive antithyroid antibodies, and thyroid dysfunction, findings consistent with APS-II. Treatment with glucocorticoids, mineralocorticoids, and hormone replacement therapy was initiated, with progressive clinical improvement.
Discussion: Autoimmune polyglandular syndrome type 2 is a challenging diagnosis due to its heterogeneous and progressive presentation. A high index of suspicion is required, especially in patients with multiple autoimmune conditions. The combination of clinical manifestations and hormonal studies allows for diagnosis and guides appropriate treatment. Although less common, hypergonadotropic hypogonadism may occur as part of the clinical spectrum.
Conclusion: This case underscores the importance of considering autoimmune polyglandular syndrome type 2 in patients with multiple autoimmune diseases. Early diagnosis enables appropriate treatment and helps prevent serious complications. Additionally, it contributes to raising awareness of this condition in Colombia, where reports remain scarce.
References
Frommer?L, Kahaly?GJ. Autoimmune Polyendocrinopathy. Journal of Clinical Endocrinology & Metabolism. 2019;104(10):4769–4782. doi:?10.1210/jc.2019-00602
Kahaly?GJ, Frommer?L. Polyglandular autoimmune syndromes. Journal of Endocrinological Investigation. 2018;41(1):91–98. doi:?10.1007/s40618-017-0740-9
Husebye?ES, Anderson?MS, Kämpe?O. Autoimmune Polyendocrine Syndromes. New England Journal of Medicine. 2018;378(12):1132–1141. doi:?10.1056/NEJMra1713301
Fernández?Miró?M, Colom?Comí?C, Godoy?Lorenzo?R. Autoinmune polyendocrinopathy. Síndromes pluriglandulares autoinmunes. Medicina Clínica. 2021;157(5):241–246. doi:?10.1016/j.medcle.2021.08.006
Michels?AW, Gottlieb?PA. Autoimmune polyglandular syndromes. Nature Reviews Endocrinology. 2010;6(5):270–277. doi:?10.1038/nrendo.2010.40
Cutolo?M. Autoimmune polyendocrine syndromes. Autoimmunity Reviews. 2014;13(2):85–89. doi:?10.1016/j.autrev.2013.07.006
Kahaly?GJ. Polyglandular autoimmune syndrome type II. Presse Médicale. 2012;41(12?Pt?2):e663–e670. doi:?10.1016/j.lpm.2012.09.011
Betterle?C, Lazzarotto?F, Presotto?F. Autoimmune polyglandular syndrome Type 2: the tip of an iceberg? Clinical and Experimental Immunology. 2004;137(2):225–233. doi:?10.1111/j.1365-2249.2004.02561.x
Fortich?Revollo?AJ, Mora?García?G, Fortich?Salvador?A, et?al. Síndrome poliglandular autoinmune tipo II en el Hospital Universitario del Caribe, Cartagena, Colombia. Revista Ciencias Biomédicas. 2011;2(1):54–62. doi:?10.32997/rcb-2011-3386
Zuluaga?Sepúlveda?MA, Jiménez?Tamayo?SB. Síndrome poliglandular autoinmune asociado a vitiligo. CES Med. 2013;27(2):227–233. DOI no disponible
Szeliga?A, Calik?Ksepka?A, Maciejewska?Jeske?M, et?al. Enfermedades autoinmunes en pacientes con insuficiencia ovárica prematura: nuestro estado actual del conocimiento. International Journal of Molecular Sciences. 2021;22(5):2594. doi:?10.3390/ijms22052594

This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
Copyright (c) 2026 Revista Colombiana de Endocrinología, Diabetes & Metabolismo

